FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Deferasirox Tablets
Status: Discontinuation
»Therapeutic Categories: Hematology

Expand all

Teva Pharmaceuticals (New 07/20/2020)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
180 mg/1 (NDC 00093-3516-56) 07/20/2020 Teva had evaluated the market and made a business decision to discontinue the product.
90 mg/1 (NDC 00093-3517-56) 07/20/2020 Teva had evaluated the market and made a business decision to discontinue the product.
360 mg/1 (NDC 00093-3515-56) 07/20/2020 Teva had evaluated the market and made a business decision to discontinue the product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English